MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3960/jslrt.21019

Медицинская библиотека · Journal of clinical and experimental hematopathology : JCEH · 2021

Better method for detection of CD30: Immunohistochemistry or flow cytometry?

Higashi Morihiro, Kikuchi Jun, Murakami Chiaki, Takayanagi Natsuko, Momose Shuji, Kizaki Masahiro, Tamaru Jun-Ichi

СтатьяПеревод пока не подготовлен

Аннотация

We compared the two methods of assessing CD30 protein expression in DLBCL and TCL specimens routinely employed at our hospital, immunohistochemistry (IHC) and flow cytometry (FCM), using the same clone of the anti-CD30 antibody (Ber-H2) in 123 patients with DLBCL and 28 patients with TCL. FCM was more sensitive than IHC, especially in cases with low expression. In three cases of TCL and two cases of DLBCL, there was discordance between these two methods. Two of these TCL cases were ALCL and one was peripheral T-cell lymphoma, NOS, but ALCL was unable to be excluded. One of two cases of DLBCL was an anaplastic variant of DLBCL. The data suggested that CD30 was undetectable, though rare, by FMC in several cases. Based on this study, a combination of IHC and FCM is recommended for the reliable and quantitative detection of CD30.

Для цитирования: Higashi Morihiro, Kikuchi Jun, Murakami Chiaki, Takayanagi Natsuko, Momose Shuji, Kizaki Masahiro, Tamaru Jun-Ichi. Better method for detection of CD30: Immunohistochemistry or flow cytometry?. Journal of clinical and experimental hematopathology : JCEH. 2021. DOI: 10.3960/jslrt.21019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.